Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.
Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M'Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network. Valmary-Degano S, et al. Among authors: m hamdi l. Eur J Surg Oncol. 2017 Oct;43(10):1915-1923. doi: 10.1016/j.ejso.2017.05.009. Epub 2017 May 18. Eur J Surg Oncol. 2017. PMID: 28619621
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Croce S, Lesluyes T, Valle C, M'Hamdi L, Thébault N, Pérot G, Stoeckle E, Noël JC, Fontanges Q, Devouassoux-Shisheboran M, Querleu D, Guyon F, Floquet A, Chakiba C, Mayeur L, Rebier F, MacGrogan GM, Soubeyran I, Le Guellec S, Chibon F. Croce S, et al. Among authors: m hamdi l. Clin Cancer Res. 2020 Feb 15;26(4):855-861. doi: 10.1158/1078-0432.CCR-19-2891. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796515
Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor.
Voisin M, de Medina P, Mallinger A, Dalenc F, Huc-Claustre E, Leignadier J, Serhan N, Soules R, Ségala G, Mougel A, Noguer E, Mhamdi L, Bacquié E, Iuliano L, Zerbinati C, Lacroix-Triki M, Chaltiel L, Filleron T, Cavaillès V, Al Saati T, Rochaix P, Duprez-Paumier R, Franchet C, Ligat L, Lopez F, Record M, Poirot M, Silvente-Poirot S. Voisin M, et al. Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9346-E9355. doi: 10.1073/pnas.1707965114. Epub 2017 Oct 12. Proc Natl Acad Sci U S A. 2017. PMID: 29078321 Free PMC article.